Ivosidenib-azacitidine in acute myeloid leukemia with IDH1 R132 mutation

被引：0
|
作者：
Mechelfekh, Yaquine [1 ]
Gastaud, Lauris [2 ]
机构：
[1] Univ Angers, CHU Angers, Lab Hematol, Angers, France
[2] Ctr Antoine Lacassagne, Serv Oncohematol, Nice, France
来源：
BULLETIN DU CANCER | 2023年 / 110卷 / 12期
关键词：
VENETOCLAX;
D O I：
10.1016/j.bulcan.2023.08.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1232 / 1233
页数：2
相关论文
共 50 条
  • [1] Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
    Pasquier, Florence
    Chahine, Claude
    Marzac, Christophe
    de Botton, Stephane
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (06): : 429 - 438
  • [2] Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
    Montesinos, Pau
    Recher, Christian
    Vives, Susana
    Zarzycka, Ewa
    Wang, Jianxiang
    Bertani, Giambattista
    Heuser, Michael
    Calado, Rodrigo T.
    Schuh, Andre C.
    Yeh, Su-Peng
    Daigle, Scott R.
    Hui, Jianan
    Pandya, Shuchi S.
    Gianolio, Diego A.
    de Botton, Stephane
    Dohner, Hartmut
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16): : 1519 - 1531
  • [3] FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
    Woods, Ashley
    Norsworthy, Kelly J.
    Wang, Xin
    Vallejo, Jonathon
    Chow, Edwin Chiu Yuen
    Li, Ruo-Jing
    Sun, Jielin
    Charlab, Rosane
    Jiang, Xiling
    Pazdur, Richard
    Theoret, Marc R.
    de Claro, R. Angelo
    CLINICAL CANCER RESEARCH, 2024, 30 (07) : 1226 - 1231
  • [4] Detection of IDH1 R132H Mutation in Acute Myeloid Leukemia by Mutation-specific Immunohistochemistry
    Byers, Richard
    Hornick, Jason L.
    Tholouli, Eleni
    Kutok, Jeffery
    Rodig, Scott J.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (01) : 37 - 40
  • [5] The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
    Bleeker, Fonnet E.
    Atai, Nadia A.
    Lamba, Simona
    Jonker, Ard
    Rijkeboer, Denise
    Bosch, Klazien S.
    Tigchelaar, Wikky
    Troost, Dirk
    Vandertop, W. Peter
    Bardelli, Alberto
    Van Noorden, Cornelis J. F.
    ACTA NEUROPATHOLOGICA, 2010, 119 (04) : 487 - 494
  • [6] Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor
    Wagner, Katharina
    Damm, Frederik
    Goehring, Gudrun
    Goerlich, Kerstin
    Heuser, Michael
    Schaefer, Irina
    Ottmann, Oliver
    Luebbert, Michael
    Heit, Wolfgang
    Kanz, Lothar
    Schlimok, Guenter
    Raghavachar, Aruna A.
    Fiedler, Walter
    Kirchner, Hartmut H.
    Brugger, Wolfram
    Zucknick, Manuela
    Schlegelberger, Brigitte
    Heil, Gerhard
    Ganser, Arnold
    Krauter, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : 2356 - 2364
  • [7] Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis
    Lin, Jiang
    Qian, Jun
    Yao, Dong-Ming
    Li, Yun
    Yang, Jing
    Chen, Qin
    Chai, Hai-yan
    Xiao, Gao-Fei
    Xu, Wen-rong
    CLINICAL BIOCHEMISTRY, 2011, 44 (10-11) : 779 - 783
  • [8] Ivosidenib in the treatment of patients with cholangiocarcinoma with an IDH1 R132 mutation who were previously treated by at least one prior line of systemic therapy
    Rabehi, Tarik
    Quesada, Stanislas
    BULLETIN DU CANCER, 2023, 110 (12)
  • [9] Sustained Clinical Response to Ivosidenib in Previously Treated Patients with Advanced Intrahepatic Cholangiocarcinoma Harboring an IDH1 R132 Mutation: Two Case Reports
    Mueller, Christian
    Franke, Sabine
    Reislaender, Timo
    Keitel, Verena
    Venerito, Marino
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 753 - 762
  • [10] Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia
    Chaturvedi, Anuhar
    Gupta, Charu
    Gabdoulline, Razif
    Borchert, Nora M.
    Goparaju, Ramya
    Kaulfuss, Stefan
    Goerlich, Kerstin
    Schottmann, Renate
    Othman, Basem
    Welzenbach, Julia
    Panknin, Olaf
    Wagner, Markus
    Geffers, Robert
    Ganser, Arnold
    Thol, Felicitas
    Haegebarth, Andrea
    Jeffers, Michael
    Heuser, Michael
    HAEMATOLOGICA, 2021, 106 (02) : 565 - 573
12345